EC Pascal Lamy Letter in Response to TACD regarding WTO Export Issue 17 December 2002
Original page: http://www.cptech.org/ip/wto/p6/lamy12172002.doc Pascal Lamy Rue de la Loi,… Continue Reading
EC Pascal Lamy Letter in Response to TACD regarding WTO Export Issue
Original: Page 1 – http://www.cptech.org/ip/health/eu/lamy2tacd20mar2002-p1.jpg Page 2 – http://www.cptech.org/ip/health/eu/lamy2tacd20mar2002-p2.jpg Note by James Love on April 1, 2002 via IP-Health email list regarding the letter below (archived link of the note here): This these are scans of Pascal Lamy’s March 20… Continue Reading
Costs of Human Use Clinical Trials: Surprising Evidence from the US Orphan Drug Act
James Love Michael Palmedo Consumer Project on Technology http://www.cptech.org November 28, 2001 Summary According to the US Internal Revenue Service (IRS), US taxpayers received Orphan Drug Tax Credits totaling $80.1 million in fy 1998, and $61.4 million in fy 1997,… Continue Reading
Implementing TRIPS safeguards with particular attention to administrative models for compulsory licensing of patents
Implementing TRIPS safeguards with particular attention to administrative models for compulsory licensing of patents WHO meeting in Harare, ZimbabweAugust 21, 2001(with additional references to November Doha declaration) James LoveConsumer Project on Technology I. Introduction. TRIPS obligations raise broad public health… Continue Reading
2001 Letter from Ralph Nader to WHO Director General Gro Harlem Brundtland
Ralph Nader P.O. Box 19312 Washington, DC 20036 July 23, 2001 Dr. Gro Harlem Brundtland Director-General World Health Organization Avenue Appia 20 1211 Geneva 27 Switzerland Dear Dr. Brundtland: It has been encouraging in recent years to see the WHO… Continue Reading
July 6, 2001 letter from DHHS Secretary Tommy G. Thompson letter to Ralph Nader Regarding WHO rights to use inventions funded by the NIH
July 6, 2001 Mr. Ralph Nader P.O. Box 19312 Washington, D.C. 20036 Dear Mr. Nader: I am writing in response to the letter from you and your colleagues requesting that the Department of Health and Human Services (HHS) grant the… Continue Reading
March 28, 2001 letter from Ralph Nader, James Love and Robert Weissman to HHS Secretary Tommy Thompson, regarding WHO right to use NIH funded inventions
Ralph Nader P.O. Box 19312 Washington, DC 20036 James Love Consumer Project on Technology P.O. Box 19367 Washington, DC 20036 Robert Weissman Essential Action P.O. Box 19405 Washington, DC 20036 March 28, 2001 Secretary Tommy Thompson Department of Health and… Continue Reading
2001: Compulsory Licensing: Models For State Practice In Developing Countries, Access to Medicine and Compliance with the WTO TRIPS Accord
Compulsory Licensing: Models For State Practice In Developing Countries, Access to Medicine and Compliance with the WTO TRIPS Accord Prepared for the United Nations Development Programme January 21, 2001 James Love Consumer Project on Technology http://www.cptech.org Introduction.1 This note addresses… Continue Reading
2000: Paying for health care R&D – Carrots and Sticks
2000: Paying for health care R&D – Carrots and Sticks James Love* October 19, 2000 *Thirukumaran Balasubramaniam provided research for this paper. Table of Contents Introduction Failures of the Market Investors cannot appropriate all the benefits of research. R&D is… Continue Reading
2000: How much does it cost to develop a new drug?
How much does it cost to develop a new drug? James Love Consumer Project on Technology http://www.cptech.org April 2, 2000 Prepared for the April 2, 2000 meeting of the MSF Working Group on R&D in Geneva. How much does it… Continue Reading